A study of Manpixiao in the treatment of chronic atrophic gastritis

illustrative image

Beijing University of Chinese Medicine is starting a new clinical trial of Clinical Study of Manpixiao in the Treatment of Chronic Atrophic Gastritis.

To explore the efficacy and safety of "Manpixiao" in the treatment of Chronic Atrophic Gastritis.

The clinical trial started in July 1, 2021 and will continue throughout December 31, 2023.

Pathological improvement rate of gastric mucosa will be primary outcome measure. Pathological diagnosis of gastric mucosal tissue samples obtained by gastroscopy.

For more details: https://ichgcp.net/clinical-trials-registry/NCT05493124.

Clinical Research News

Upcoming Clinical Trials